SIMPONI (golimumab) 50 mg and 100 mg: Important Changes to the Patient Information Leaflet (PIL) for the SmartJect (pre-filled pen)

A Dear Healthcare Professional Letter has been issued by Johnson & Johnson International (Singapore) Pte. Ltd. to inform healthcare professionals of the important changes to the patient information leaflet (PIL) for the SIMPONI SmartJect pre-filled pen. This followed identified safety issues such as accidental needle stick injuries from skin pinching when administering the injection and failure of the device to actuate from prematurely pressing the button. Healthcare professionals are advised to inform all patients and caregivers on the proper use of the SmartJect pre-filled pen, in accordance with the revised PIL. Please refer to the letter for details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.